The golden age of global health: sustainability as an aspiration
The framing of the concept of sustainability in global health has evolved substantially since the late 1990s. Over the past 20 years, the ideals that health is a fundamental human right and that high-income countries have both a moral duty and long-term interest in assisting low-income and middle-income countries have made an encouraging comeback. We now know that the economic consequences of a lack of health services (due to labour productivity, orphaned children and effects on educational attainment) were likely so significant as to be greater than their costs in economic terms alone.40 The HIV/AIDS pandemic and the Millennium Development Goals (which included health targets for maternal health, child health, HIV, tuberculosis and malaria) catalysed the implementation of initiatives of much greater reach and scope than those implemented just a decade earlier.41–45 The Global Fund to Fight AIDS, Tuberculosis and Malaria, the President’s Emergency Plan for AIDS Relief, GAVI, the Vaccine Alliance and the Bill & Melinda Gates Foundation have been able to marshal and deploy considerably more funding than before.23 46–48
In this new era (known as the golden age of global health), sustainability became an aspiration, an ambitious but poorly defined goal—a metaphorical star in the sky (figure 1C). With this framing, there has often been a profound mismatch between the aspirational rhetoric adopted by many powerful actors within the global health ecosystem and their actual priorities, incentives and behaviour. When it was not in open conflict with the pursuit of sustainability, this behaviour in many cases has prevented progress from occurring at a greater scale and speed. It is also important to note how the earlier framing of sustainability as a constraint has persisted together with the new framing of sustainability as an aspiration.
The conservative and fragmented approaches of the post Alma Ata Declaration years gave way to more holistic and integrated approaches that acknowledged the importance of both prevention and treatment, especially of infectious diseases such as HIV and tuberculosis as well as malaria and other neglected tropical diseases. Development assistance for health increased from approximately US$7 billion in the late 1990s to almost US$40 billion by the early 2010s.23 46 Between 1995 and 2014, average per capita health spending increased to over US$900 /year in upper middle-income countries, over US$250 in lower-middle-income countries, and approximately US$120 /year in low-income countries.46 Tens of millions of people received antiretroviral drugs, and treatment for multidrug-resistant tuberculosis has become widely available in most countries.49 50 While many initiatives have remained ‘vertical’ in that they address a specific set of diseases, considerable efforts have been made to leverage their resources to strengthen health systems more broadly (or ‘diagonally’).51 A fairer and more realistic assessment of peoples’ and communities’ agency, vulnerability and resilience has led to a renewed appreciation of the importance of social, economic, legal, political and environmental determinants of health.45 52–58
Despite these achievements, significant challenges remain. Misguided free market principles continue to overly influence global health.59 60 There are growing attempts at balancing the market through corporate social responsibility, private philanthropy, public–private partnerships, social entrepreneurship and legislation.53 60 61 New intellectual property laws, voluntary licensing agreements and pooled funding for research and development as well as procurement, utilisation of generic medications and development of frugal technologies have made (or have the potential to make) certain health technologies (like antiretroviral drugs) more readily available to disadvantaged countries and communities.49 50 53 54 62–64 However, limited access to life-saving health technologies has continued to thwart many initiatives globally.
While there has been a significant (but still insufficient) redistribution of resources from foreign to national actors, redistribution of other sources of power has proved more difficult. Some donors have often opted to channel funding primarily through international NGOs and academic institutions rather than their counterparts from disadvantaged countries and communities.48 65 66 The same donors have also driven most of the agenda by choosing what priorities to address (often favouring disease (especially infectious)-specific initiatives over health system strengthening ones), prescribing how funding should be spent,and determining the timeline for the implementation of most initiatives.48 65 66 The result has been a persistent mismatch between the actual burden of diseases and the allocation of funding, which has hampered the pursuit of self-sufficiency in disadvantaged countries and communities.67
The current average per capita health expenditure for low-income countries is barely enough to provide a very basic level of universal health coverage, but not nearly enough to achieve all of the remaining health targets within the third Sustainable Development Goal.46 68 69 Simultaneously, there has been no systematic plan to replace development assistance for health with government health expenditure in supported countries, especially in those transitioning from low-income to middle-income status.69 70 As a result, out-of-pocket health expenditure has increased substantially in these countries and will continue to do so shortly.46
Despite the acknowledgement of the role that historical and current injustices (colonialism, excessive debt obligations, corruption and commercial exploitation) played in creating the current state of affairs, the previous power structures remained.10–12 Instead, a misapplication of the idea of ‘win-win’ solutions (the belief that meaningful societal change can always occur without major disruptions of the status quo) has become ubiquitous, especially as it pertains to many problematic public–private partnerships.71–74
With these persistent governance issues, progress, although substantial, has been uneven. Morbidity and mortality from HIV, tuberculosis and malaria have decreased. However, these diseases are not yet under control and maintaining previous gains has proven to be challenging.6 49 75 Neonatal disorders remain the greatest burden of disease globally, measured by disability-adjusted life-years. Despite significant improvements, low-income and middle-income countries still bear 94% of the burden of maternal mortality.75 76 Little has been done to prevent and treat NCDs, surgical conditions, cancer and mental illnesses.77–82 The global health ecosystem has proved to be increasingly vulnerable to a novel epidemic and pandemic diseases.83 84 While the Ebola epidemic in West Africa was ultimately contained, the current COVID-19 pandemic has gravely damaged the health systems of countries worldwide. Lastly, the global health ecosystem has only the most nascent of strategies to combat the negative impact of climate change and environmental degradation.57 58
With sustainability framed as an aspiration (figure 1C) and without a roadmap to achieve it, it remains unclear how exactly, when or whether actors providing outside support should ‘work themselves out of a job’ and coordinate the transition with disadvantaged countries and communities without compromising health outcomes.70 85 Some overlap between the need to sustain health outcomes and the pressure to maintain the existing power structures (figure 1D) has persisted.3 Additionally, process indicators of sustainability (documenting, for example, the development of new policies and procedures by global health actors) have taken precedence of quality indicators (measuring the extent to which these new policies and procedures have resulted in high-quality implementation and scale-up of new practices).86 The feedback loop between health outcomes and actors has remained skewed in favour of actors with the most power39 who continue to determine most of the outcomes to pursue and select most of the metrics for measuring success.